Innovation in the Open
An article on the Chemistry World website noted a trend in open innovation: rather than drawing start-ups closer to obtain their intellectual property, some firms are shifting to a more collaborative approach. This strategy foresees collaboration agreements, or business support, and subsequent shared ownership of intellectual property (IP) as a way
Comments Off on Innovation in the Open • Read this story »
More Articles
Connect and Compete Through Open Innovation
The MDDI website noted that open innovation has become a mainstream practice for most technology-driven companies looking to accelerate time to market and stay ahead of the competition; and added if you are a medical technology manufacturer considering open innovation as a strategy within your innovation
Comments Off on Connect and Compete Through Open Innovation • Read this story »
Opening Up Innovation
The pmlive website noted that the [pharma] industry is increasingly open to academic collaborations and alongside this a more radical step can be seen in pharma’s willingness to move beyond ‘not invented here’ and take part in ‘open innovation’ initiatives. The trend is
Comments Off on Opening Up Innovation • Read this story »
Fighting for Innovation Attention
The Innovation Excellence website reported that Apple, Lego, Philips, Samsung, IBM, GSK and, recently, Tata Steel, among many others – all have adopted open innovation initiatives to expand their organizations’ horizons. Open innovation allows you to break down more traditional corporate walls and
Comments Off on Fighting for Innovation Attention • Read this story »
GSK, Crick Institute Partner on Open R&D
The Drug Discovery and Development website reported that the Francis Crick Institute and GSK, the UK’s largest pharmaceutical company, are to partner on an open innovation collaboration exploring new avenues of medical research and drug discovery across a broad range of diseases. In the spirit of open
Comments Off on GSK, Crick Institute Partner on Open R&D • Read this story »
Open Labs Key to Cracking Toughest Health Problems?
The Policy Innovations website noted that there’s now a growing consensus that the open innovation approach is key to tackling disease in the developing world. GlaxoSmithKline’s (GSK) Open Lab has turned the traditional research and development (R&D) model of closed innovation—of companies
Comments Off on Open Labs Key to Cracking Toughest Health Problems? • Read this story »
New Treatments Developed in Open Innovation Program
The University of Cambridge website reported that Cambridge researchers are developing new therapies as part of a collaborative program with industry. Two revolutionary treatments which could alleviate pain in people with hypersensitivity to heat, and provide a new regenerative therapy with MS
Comments Off on New Treatments Developed in Open Innovation Program • Read this story »
GlaxoSmithKline: Funding Open Innovation
The 4-Traders website reported that GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discovering and developing urgently needed new treatments for diseases of the developing world. The funding will move early-stage research
Comments Off on GlaxoSmithKline: Funding Open Innovation • Read this story »
Open Innovation In Practice
The Edge Online website posted an article which notes that finding new ways to create value for your organization is a constant challenge in an ever-changing business landscape. One approach, open innovation, has been increasingly applied to great effect in high tech and R&D intensive industries.
Comments Off on Open Innovation In Practice • Read this story »
Will Pharma Embrace Open Innovation?
The PharmTech website notes that recent years of low approvals of new blockbuster products have given rise to the perception that pharmaceutical drug development, in its current format, no longer works. Recent late-stage failures of clinical trials have also served to emphasize the risky nature of
Comments Off on Will Pharma Embrace Open Innovation? • Read this story »